SI-6603 (Condoliase) Study for Lumbar Disc Herniation (Discovery 6603 Study)

Status:
Recruiting

Trial end date:
2022-11-01

Target enrollment:

Participant gender:

This study is to evaluate the effectiveness of a single-dose intervertebral disc injection of SI-6603 in subjects with lumbar disc herniation (LDH)

Phase 3

Seikagaku Corporation